跳至主要内容
临床试验/ACTRN12615000147583
ACTRN12615000147583
已完成
未知

In middle aged men with the Metabolic Syndrome, does the ingestion of palmitic acid rich fats, compared with palmitic acid poor fats, acutely affect postprandial chylomicron composition.

Auckland UniServices0 个研究点目标入组 40 人2015年2月17日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Metabolic Syndrome
发起方
Auckland UniServices
入组人数
40
状态
已完成
最后更新
6年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2015年2月17日
结束日期
待定
最后更新
6年前
研究类型
Interventional
性别
Male

研究者

发起方
Auckland UniServices

入排标准

入选标准

  • 45\-60 years old
  • BMI of 18\-25 kg/m2
  • Healthy (no current or past history of the Metabolic Syndrome as defined by the International Diabetes Federation)
  • 45\-60 years old
  • BMI greater than 25 kg/m2
  • Metabolic Syndrome as defined by the International Diabetes Federation: central obesity (waist circumference greater than/equal to 94cm PLUS any two of:
  • \* raised TG concentrations (greater than/equal to 1\.7 mmol/L or undergoing treatment)
  • \* reduced HDL\-C (\<1\.03 mmol/L or undergoing treatment)
  • \* raised blood pressure (greater than/equal to 130/85 mmHg or undergoing treatment)
  • \* raised fasting plasma glucose (greater than/equal to 5\.6 mmol/L or previously diagnoses T2DM)

排除标准

  • History of CVD disease/complications (myocardial infarction, angina, stroke)
  • History of cancer
  • Pre\-existing diabetes
  • Self reported alcohol intake exceeding a moderate intake (\>28 units/week)
  • Abnormal liver function or haematology

结局指标

主要结局

未指定

相似试验